No volume

Volume has been low on the decline and this morning it's weak on the rise. We need to see some good 2Q sales from Kadcyla to help drive new investors into the stock. IMGN's efforts to attract new investors through public appearances does not seem to be effective. Other than John Lambert, I am not impressed with IMGN execs. Listen to the ECYT cc replay from Jeffries, their CFO blows Junius away IMO. Here we go, rally is already failing in the time to took me to write this! Back to the day job, no retirement today!

I really don't think this is as much a problem with IMGN as it is with the market in general. The general market has not had 3 days of pull-back in 106 sessions, and a correction is due. The previous record was 53 sessions. It's been a good ride and I expect this is a temporary setback and it is close to being a time to buy. I truly believe the technology behind this company is just getting going, and growth is on it's way soon.

Most of my portfolio is down. I would say given ImmunoGen is staying in the 16's is pretty good sign of the health of this stock. In previous years this stock would drop like a stone during down times in the market.

Yahoo! Finance Worldwide

Quotes are real-time for NASDAQ, NYSE, and NYSEAmex when available. See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.